Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Carolyn J. Oxencis PharmD

Carolyn J. Oxencis PharmD profile photo picture

Adjunct Associate Professor

Institution: Medical College of Wisconsin
Department: School of Pharmacy Operations


I am willing to collaborate on research projects.
I am willing to be a peer mentor.
I am willing to mentor a junior faculty member.

Publications (10)

  • Pharmacogenetic Evaluation of Hospitalized Patients Requiring Naloxone for Reversal of Acute Opioid Toxicity. (Grahl J, Mills M, Singh A, Oxencis C, Mohr A, Mancuso T, Teng BQ, Bajorunaite R, Carver T, Peppard WJ) Hosp Pharm 2025 May 20:00185787251339360 PMID: 40406364 PMCID: PMC12092407 SCOPUS ID: 2-s2.0-105005872042 05/23/2025    
  • Pharmacist perspectives on emerging T cell-engaging bispecific therapies in cancer therapeutics. (Moore DC, Digiantonio N, Oxencis CJ, Taucher KD) Am J Health Syst Pharm 2024 Jul 08;81(14):574-582 PMID: 38394329 SCOPUS ID: 2-s2.0-85194354207 02/23/2024       3 Citations
  • Feasibility of a pharmacist-led symptom monitoring and management intervention to improve breast cancer endocrine therapy adherence. (Neuner J, Weil E, Fergestrom N, Stolley M, Kamaraju S, Oxencis C, Winn A, Laud PW, Flynn KE) J Am Pharm Assoc (2003) 2022;62(4):1321-1328.e3 PMID: 35393248 SCOPUS ID: 2-s2.0-85127492109 04/09/2022       7 Citations
  • New and emerging pharmacotherapies for the management of multiple myeloma. (Moore DC, Oxencis CJ, Shank BR) Am J Health Syst Pharm 2022 Jul 08;79(14):1137-1145 PMID: 35333922 SCOPUS ID: 2-s2.0-85134360892 03/26/2022       6 Citations
  • Principles of Drug Metabolism and Interactions in Cardio-Oncology: Drug Interactions in Cardio-Oncology (Brown SA, Beavers C, Kamaraju S, Mohan M, Fatunde O, Echefu G, Zaharova S, Wallace B, Oxencis C) Drug Metabolism Handbook Concepts and Applications in Cancer Research 1 January 2022:967-992 SCOPUS ID: 2-s2.0-85148796959 01/01/2022       1 Citation
  • ASHP Statement on the Pharmacist's Role in Clinical Pharmacogenomics. (Haidar CE, Petry N, Oxencis C, Douglas JS, Hoffman JM) Am J Health Syst Pharm 2022 Apr 01;79(8):704-707 PMID: 34487145 SCOPUS ID: 2-s2.0-85128161244 09/07/2021       52 Citations
  • TAS-102: A resurrected novel Fluoropyrimidine with expanding role in the treatment of gastrointestinal malignancies. (Chakrabarti S, Wintheiser G, Tella SH, Oxencis C, Mahipal A) Pharmacol Ther 2021 Aug;224:107823 PMID: 33667525 SCOPUS ID: 2-s2.0-85102047484 03/06/2021       16 Citations
  • Evaluation of the Pharmacokinetics and Efficacy of a Busulfan Test Dose in Adult Patients Undergoing Myeloablative Hematopoietic Cell Transplantation. (Weil E, Zook F, Oxencis C, Canadeo A, Urmanski A, Waggoner M, Eastwood D, Pasquini M, Hamadani M, Hari P) Biol Blood Marrow Transplant 2017 Jun;23(6):952-957 PMID: 28288949 SCOPUS ID: 2-s2.0-85017516033 03/16/2017       20 Citations
  • Pharmacist collaborative practice agreement for the management of anemia in malignant disease with erythropoiesis-stimulating agents. (Weil E, Oxencis C) Support Care Cancer 2015 Aug;23(8):2507-13 PMID: 25971214 SCOPUS ID: 2-s2.0-84933182775 05/15/2015       9 Citations
  • Medication reconciliation at an academic medical center: implementation of a comprehensive program from admission to discharge. (Murphy EM, Oxencis CJ, Klauck JA, Meyer DA, Zimmerman JM) Am J Health Syst Pharm 2009 Dec 01;66(23):2126-31 PMID: 19923314 SCOPUS ID: 2-s2.0-73649116397 11/20/2009       109 Citations
    • Last update: 02/06/2026